Group
Acquisition
Evonik acquires PeroxyChem for US$ 625 million ... MORE
Company
Quarterly Reports
Evonik will publish its quarterly report Q4 2018 on March 5, 2019. You can access further information here. ... MORE
Company
Meet the Management
At the “Meet the Management” on September 14th, 2018 in London, Deputy CEO Dr. Harald Schwager and the chairmen of the segments Dr. Reiner Beste (Nutrition & Care) as well as Dr. Claus Rettig (Resource Efficiency) will present to institutional investors and financial analysts in London. ... MORE
Further Information
Company
Events & Presentations
Here you will find dates, information and presentations on our events. ... MORE
Company
Analysts' estimates
Evonik Industries AG is covered by German and international financial analysts, who provide their own research analyses and earnings estimates in respect of the company. ... MORE
Company
News & Reports
Here you can find "Investor Relations News" with the latest news from our company, plus our most recent interim reports, annual reports and corporate responsibility reports. ... MORE
Reporting 2018 / 2019
Investor Relations
Feb 13, 2019
Evonik More Than Doubles Venture Capital to Accelerate Innovation
Evonik has launched its second venture capital fund with a volume of €150 million, more than doubling the amount under management to €250 million. ... MORE
Investor Relations
Nov 30, 2018
Evonik appoints new managers to its segments’ boards
Johann-Caspar Gammelin, currently Chairman of the Board of Management of Evonik Performance Materials GmbH, will take over as Chairman of the Board of Management of Evonik Nutrition and Care GmbH from Dr. Reiner Beste, effective April 1, 2019. ... MORE
Investor Relations
Nov 08, 2018
Evonik acquires PeroxyChem for US$625 million
PeroxyChem is a manufacturer of hydrogen peroxide (H2O2) and peracetic acid (PAA) and is well positioned in high-margin specialty applications.
... MORE
Investor Relations
Nov 07, 2018
Evonik strengthens its activities in Precision Livestock Farming with acquisition of Belgian Big Data software provider Porphyrio
On 31 October 2018 Evonik Industries completed the acquisition of Porphyrio NV, the KU Leuven spin-off company head-quartered in Herent (Belgium). ... MORE
Investor Relations
Nov 06, 2018
Good results in third quarter
Evonik increased adjusted EBITDA to €692 million in the third quarter of 2018 (prior-year: €640 million). ... MORE
Investor Relations
Nov 02, 2018
Evonik invests in precision livestock start-up to improve poultry production
Evonik has invested in the startup OPTIfarm Ltd. through its venture capital unit and now holds a minority stake in the company, which is headquartered in Chesterfield (United Kingdom). ... MORE
Further Information
Company
Financial data
Evonik is active in over 100 countries around the world. In fiscal 2017 more than 36,500 employees generated sales of €14.4 billion and an adjusted EBITDA of €2.360 billion. ... MORE
Company
Bonds & Rating
Evonik maintains a centralized approach to financing. Liabilities for credit and loans are fully guaranteed by Evonik Industries AG. ... MORE
Company
Key Figures Share
Here you find information about Evonik shares. ... MORE
Company
Contact & Service
You can find the contacts in the Investor Relations Department here. ... MORE
Company
Disclaimer
Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained. ... MORE
Company
Corporate Governance
As a globally active company, we have to comply with a wide range of statutory regulations and cultural standards. ... MORE
Company
Sustainable Investment (SRI)
We accept responsibility for our businesses, our employees, the environment and the society. ... MORE
Company
Starter-Kit Investor Relations
Find additional information and data on Evonik Industries AG on our "Starter-Kit" website. ... MORE
